FBIO
Fortress Biotech Inc
2.10$
+2.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 4.2% | 87.1% | 86.1% | 85.3% | 87.3% | 85.0% | 82.6% | 80.8% | 79.2% | – | 29.1% | 25.8% | 27.7% | 32.0% | 29.5% | 33.0% | 35.7% | 35.5% | 33.7% | 41.9% | 53.0% | 56.3% | 34.3% | 40.4% | 43.7% | 52.1% | 51.9% | 44.7% | 18.5% | 30.2% | 46.1% | 43.9% | 36.1% | 38.4% | 36.5% | 30.1% | 32.6% | 33.8% | 45.8% | 38.0% | 37.5% | |
| 95.8% | 12.9% | 13.9% | 14.7% | 12.7% | 15.0% | 17.4% | 19.2% | 20.8% | – | 70.9% | 74.2% | 72.3% | 68.0% | 70.5% | 67.0% | 64.3% | 64.5% | 66.3% | 58.1% | 47.0% | 43.7% | 65.7% | 59.6% | 56.3% | 47.9% | 48.1% | 55.3% | 81.5% | 69.8% | 53.9% | 56.1% | 63.9% | 61.6% | 63.5% | 69.9% | 67.4% | 66.2% | 54.2% | 62.0% | 62.5% | |
| 852.9% | 83.8% | 18.8% | 26.6% | 34.5% | 31.8% | 45.2% | 27.4% | 31.1% | – | 366.3% | 202.3% | 156.3% | 212.2% | 117.0% | 182.6% | 145.2% | 130.6% | 173.9% | 189.6% | 133.2% | 235.6% | 153.5% | 175.4% | 180.9% | 214.1% | 317.9% | 184.9% | 58.6% | 70.6% | 190.6% | 85.1% | 64.6% | 65.7% | 30.0% | 49.5% | 1.2% | 2.3% | 3.4% | 4.3% | 2.8% | |
| 909.1% | 77.3% | 30.1% | 29.7% | 32.2% | 0.6% | 34.7% | 20.5% | 19.1% | – | 208.1% | 145.3% | 146.7% | 128.8% | 120.1% | 152.9% | 162.4% | 329.9% | 151.4% | 108.6% | 105.4% | 151.6% | 109.8% | 153.8% | 182.4% | 171.9% | 203.9% | 140.6% | 62.5% | 113.4% | 137.7% | 139.8% | 150.3% | 177.7% | 195.3% | 236.1% | 98.8% | 91.6% | 99.1% | 111.2% | 100.6% | |
| 1,762.1% | 165.4% | 52.3% | 60.4% | 82.2% | 76.4% | 81.4% | 47.9% | 50.2% | – | 574.4% | 347.6% | 303.0% | 341.0% | 237.2% | 335.5% | 307.5% | 241.2% | 325.3% | 298.2% | 283.8% | 383.0% | 263.3% | 329.2% | 363.3% | 381.0% | 521.7% | 343.5% | 121.1% | 168.2% | 334.6% | 242.6% | 214.9% | 242.5% | 233.4% | 292.1% | 106.0% | 96.0% | 102.5% | 115.5% | 105.4% | |
| -1,666.3% | -152.5% | -39.3% | -45.7% | -69.5% | -61.4% | -61.7% | -39.8% | -44.3% | – | -503.4% | -273.4% | -230.7% | -273.0% | -166.7% | -268.5% | -243.2% | -176.8% | -259.1% | -240.2% | -236.8% | -339.2% | -197.6% | -269.6% | -307.0% | -333.1% | -473.6% | -288.2% | -39.6% | -98.3% | -280.6% | -186.5% | -151.0% | -180.9% | -169.9% | -222.2% | -38.6% | -29.8% | -48.3% | -53.5% | -42.9% | |
| 70.7% | 14.7% | 1.6% | 2.7% | 6.9% | 1.2% | 4.3% | 4.1% | 4.2% | – | 38.1% | 33.6% | 32.4% | 27.9% | 24.2% | 32.3% | 73.4% | 15.9% | 18.9% | 15.5% | 21.1% | 32.4% | 9.8% | 16.7% | 20.5% | 28.9% | 34.6% | 20.9% | 7.3% | 10.3% | 20.0% | 14.2% | 42.4% | 17.2% | 19.1% | 12.6% | 13.7% | 10.6% | 21.0% | 7.9% | 13.1% | |
| -1,739.1% | -168.9% | -32.6% | -45.3% | -77.4% | -54.1% | -65.2% | -53.7% | -43.4% | – | -251.0% | -297.1% | -255.5% | -296.1% | -186.3% | -301.0% | -316.2% | -148.0% | -225.0% | -136.7% | -217.5% | -372.3% | -206.8% | -285.6% | -321.0% | -347.5% | -443.7% | -341.1% | -30.5% | -143.4% | -299.5% | -193.5% | -182.0% | -171.8% | -187.9% | -71.0% | 50.2% | -38.6% | 887.2% | 4.8% | 213.0% | |
| -337.0% | 97.7% | -5.0% | -8.3% | -13.3% | 3.3% | -27.4% | 2.3% | 1.5% | – | -243.9% | -121.9% | -117.4% | 397.5% | -72.1% | -127.8% | -78.7% | 1.0% | -132.6% | -104.7% | -101.3% | 2.6% | -166.0% | -197.0% | -214.4% | 2.7% | -265.8% | -166.4% | 0.4% | 1.9% | -13.2% | -17.2% | 0.5% | 2.2% | – | – | 0.1% | -5.1% | 32.0% | 1.6% | 6.8% | |
| -1,331.4% | -138.2% | -26.8% | -34.3% | -57.8% | -23.0% | -37.9% | -33.9% | -26.1% | – | 21.5% | -141.6% | -130.6% | -139.2% | -95.8% | -140.8% | -164.1% | -38.5% | -76.1% | -19.8% | -98.6% | -172.7% | -65.9% | -113.1% | -136.2% | -164.3% | -173.3% | -142.5% | -14.5% | -46.5% | -118.3% | -73.5% | -88.0% | -44.7% | -80.6% | 94.4% | 33.2% | -24.5% | 688.2% | -2.5% | 163.3% | |
| -1,649.6% | -149.0% | -29.2% | -40.9% | -68.8% | -50.9% | -61.1% | -39.1% | -43.4% | – | -205.5% | -252.1% | -210.5% | -256.8% | -158.0% | -254.5% | -236.8% | -122.2% | -194.9% | -114.6% | -191.6% | -330.7% | -187.8% | -260.0% | -284.3% | -302.7% | -401.6% | -301.4% | -17.1% | -127.2% | -275.0% | -175.5% | -144.0% | -144.0% | -159.8% | -51.3% | 70.5% | -20.8% | 918.8% | 17.9% | 233.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.